Vocare bladder system

Vocare™ bladder system

Neurology A neuroprosthetic device which provides electrical stimulation to promote bladder control in Pts with spinal cord injuries. See Urinary incontinence.
References in periodicals archive ?
The VOCARE Bladder System received FDA Approval under the Humanitarian Device Exemption (HDE) provision in early 1999 and more than 1,600 people have received the implant worldwide.
NeuroControl Corporation The Vocare Bladder System is an implemented device that may restore bladder function to people with complete spinal cord injury.
The VOCARE Bladder System received FDA Clearance in early 1999 and more than 1,900 people have received the implant worldwide.
In BW1141-1/5, (NEUROCONTROL) VOCARE Bladder System Receives FDA Approval released Jan.
The VOCARE Bladder System received FDA Approval in early 1999 and more than 1,900 people have received the implant worldwide.
Called the VOCARE Bladder System, this neuroprosthetic device for people with complete spinal cord injury at any level allows people to empty the bladder without the use of catheters, medications or adaptive equipment.
CLEVELAND--(BW HealthWire)--June 23, 1998--NeuroControl Corporation announced today that it has received notification from the Food and Drug Administration (FDA) that its VOCARE Bladder System has qualified for Humanitarian Use Device (HUD) designation for use by people with complete spinal cord injuries.
The VOCARE Bladder System restores bladder and bowel function in men and women with complete spinal cord injury.
The company is seeking qualified candidates for its Freehand System and its Vocare Bladder System, an implant designed to restore significant bladder function in men and women with spinal cord injuries.
Craig Hospital announced today that it has recice restores this function through the use of electrical stimulation to replace the brain's original nerve impulses which, when interrupted through spinal cord injury, e distributor of the VOCARE Bladder System.
The company is currently conducting clinical trials for its Freehand System and the Vocare Bladder System, an implant designed to restore significant bladder function in men and women with spinal cord injuries.
NYSE/PSE:THC), Monday announced that its Meadowcrest Hospital in New Orleans has been selected to participate in an FDA-approved national clinical study of the VOCARE Bladder System, an implantable device designed to restore bladder control for men and women with spinal cord injuries.